Two Sigma Investments
KRSA

Two Sigma Investments’s Korsana Biosciences, Inc. Common Stock KRSA Stock Holding History

Two Sigma Investments’s Portfolio KRSA Stock Details KRSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-5,936
Closed -$52.8K – 4643
2025
Q4 		$52.8K Buy
5,936
+4,037
+213% +$7.21K ﹤0.01% 3928
2025
Q3 		$30.6K Buy
+1,899
New +$5.16K ﹤0.01% 3570
2022
Q2 		– Sell
-303
Closed -$47K – 2596
2022
Q1 		$47K Sell
303
-680
-69% -$16.4K ﹤0.01% 2493
2021
Q4 		$237K Sell
983
-1,807
-65% -$85.4K ﹤0.01% 3810
2021
Q3 		$1.2M Buy
2,790
+1,692
+154% +$111K ﹤0.01% 2447
2021
Q2 		$599K Sell
1,098
-23
-2% -$1.44K ﹤0.01% 2938
2021
Q1 		$438K Buy
1,121
+351
+46% +$26.4K ﹤0.01% 3052
2020
Q4 		$330K Buy
+770
New +$52.5K ﹤0.01% 2784
2020
Q1 		– Sell
-701
Closed -$267K – 3240
2019
Q4 		$267K Buy
+701
New +$65.5K ﹤0.01% 3270

Other funds holding KRSA

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
KA
Kovack Advisors Ft. Lauderdale, Florida $2.08B AUM 38.95% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

Two Sigma Investments's KRSA Position: Q1 2026 in Review

Two Sigma Investments sold out of Korsana Biosciences, Inc. Common Stock (KRSA) in Q1 2026, closing a stake of 5,936 shares — an estimated $52.8K sold.

Two Sigma Investments first reported a position in KRSA in Q4 2019 and held it in 9 quarters. The position peaked at $1.2M in Q3 2021. 16 funds tracked by Wall St. Rank hold KRSA as of Q1 2026.

  • Two Sigma Investments reported no remaining Korsana Biosciences, Inc. Common Stock position as of Q1 2026 after selling out during the quarter.
  • Two Sigma Investments sold 5,936 Korsana Biosciences, Inc. Common Stock shares in Q1 2026, an estimated $52.8K.
  • Two Sigma Investments first reported a position in Korsana Biosciences, Inc. Common Stock in Q4 2019 and held it in 9 quarters.
  • Two Sigma Investments's Korsana Biosciences, Inc. Common Stock position peaked at $1.2M in Q3 2021.
  • 16 funds tracked by Wall St. Rank held Korsana Biosciences, Inc. Common Stock as of Q1 2026.

Based on Two Sigma Investments's 13F filing for Q1 2026, filed 15 May 2026.